Early immune events in the induction of allergic contact dermatitis

Nature Reviews Immunology

Volumn 12, Issue 2, 2012, Pages 114-124

  Kaplan, Daniel H ^a   Igyártó, Botond Z ^a   Gaspari, Anthony A ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CHLORPHENIRAMINE MALEATE; GLUCOCORTICOID; HAPTEN; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR;

ALLERGIC ASTHMA; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL MIGRATION; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTACT DERMATITIS; DENDRITIC CELL; DISEASE EXACERBATION; DRUG EXPOSURE; ECZEMA; ENZYME MECHANISM; HAPTEN CARRIER COMPLEX; HELPER CELL; HOUSE DUST; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; KERATINOCYTE; LANGERHANS CELL; MAST CELL; NONHUMAN; NUCLEOPHILICITY; PATCH TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SKIN INFLAMMATION; SKIN SENSITIZATION; XENOBIOTIC STRESS;

ALLERGENS; DENDRITIC CELLS; DERMATITIS, ALLERGIC CONTACT; HUMANS; IMMUNITY, INNATE; MAST CELLS; MODELS, IMMUNOLOGICAL; RECEPTORS, PATTERN RECOGNITION; SKIN; TIME FACTORS;

EID: 84856234422     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3150     Document Type: Review

References (125)

1. Mowad, C. M. Patch testing: pitfalls and performance. Curr. Opin. Allergy Clin. Immunol. 6 , 340-344 (2006). (Pubitemid 44368240)
2. Thyssen, J. P., Linneberg, A., Menne, T. & Johansen, J. D The epidemiology of contact allergy in the general population - prevalence and main findings. Contact Dermatitis 57 , 287-299 (2007). (Pubitemid 47568789)
3. Diepgen, T. L. Occupational skin-disease data in Europe. Int. Arch. Occup. Environ. Health 76, 331-338 (2003). (Pubitemid 36992293)
4. Diepgen, T. L. & Coenraads, P. J. The epidemiology of occupational contact dermatitis. Int. Arch. Occup. Environ. Health 72, 496-506 (1999). (Pubitemid 29535197)
5. Martin, S. F. T lymphocyte-mediated immune responses to chemical haptens and metal ions: implications for allergic and autoimmune disease. Int. Arch. Allergy Immunol. 134, 186-198 (2004). (Pubitemid 38813031)
6. Vocanson, M. et al. Contribution of CD4+ and CD8+ T-cells in contact hypersensitivity and allergic contact dermatitis. Expert Rev. Clin. Immunol. 1 , 75-86 (2005).
7. Martin, S. F. et al. Fas-mediated inhibition of CD4+ T cell priming results in dominance of type 1 CD8+ T cells in the immune response to the contact sensitizer trinitrophenyl. J. Immunol. 173, 3178-3185 (2004). (Pubitemid 39142024)
8. Watanabe, H., Unger, M., Tuvel, B., Wang, B. & Sauder, D. N. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J. Interferon Cytokine Res. 22, 407-412 (2002). (Pubitemid 34579542)
9. Landsteiner, K. & Jacobs, J. Studies on the sensitization of animals with simple chemical compounds. III. Anaphylaxis induced by arsphenamine. J. Exp. Med. 64, 717-721 (1936).
10. Aptula, A. O. & Roberts, D. W. Mechanistic applicability domains for nonanimal-based prediction of toxicological end points: general principles and application to reactive toxicity. Chem. Res. Toxicol. 19, 1097-1105 (2006). (Pubitemid 44384841)
11. Roberts, D. W. & Aptula, A. O. Determinants of skin sensitisation potential. J. Appl. Toxicol. 28, 377-387 (2008). (Pubitemid 351518126)
12. Divkovic, M., Pease, C. K., Gerberick, G. F. & Basketter, D. A. Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization. Contact Dermatitis 53 , 189-200 (2005). (Pubitemid 41508973)
13. Aptula, A. O., Roberts, D. W. & Pease, C. K. Haptens, prohaptens and prehaptens, or electrophiles and proelectrophiles. Contact Dermatitis 56, 54-56 (2007). (Pubitemid 44924273)
14. Smith, C. K. & Hotchkiss, S. A. M. Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms 119-205 (Taylor and Francis, London, 2001).
15. Smith, C. K. & Hotchkiss, S. A. M. Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms 89-117 (Taylor and Francis, London, 2001).
16. Kalgutkar, A. S. et al. A comprehensive listing of bioactivation pathways of organic functional groups. Curr. Drug Metab. 6, 161-225 (2005). (Pubitemid 40753853)
17. Lepoittevin, J. P. Metabolism versus chemical transformation or pro- versus prehaptens? Contact Dermatitis 54, 73-74 (2006).
18. Akira, S., Uematsu, S. & Takeuchi, O. Pathogen recognition and innate immunity. Cell 124, 783-801 (2006). (Pubitemid 43261452)
19. Sloane, J. A., Blitz, D., Margolin, Z. & Vartanian, T. A clear and present danger: endogenous ligands of Toll-like receptors. Neuromolecular Med. 12, 149-163 (2010).
20. Martin, S. F. et al. Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity. J. Exp. Med. 205 , 2151-2162 (2008).
21. Martin, S. F. et al. Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 66, 1152-1163 (2011).
22. Scheibner K.A., et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2 J. Immunol. 2006 177 1272-1281 (Pubitemid 44036633)
23. Termeer, C. et al. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195, 99-111 (2002). (Pubitemid 34074500)
24. Stern, R., Kogan, G., Jedrzejas, M. J. & Soltes, L. The many ways to cleave hyaluronan. Biotechnol. Adv. 25, 537-557 (2007). (Pubitemid 47464847)
25. Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27, 229-265 (2009).
26. Sutterwala, F. S. et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24 , 317-327 (2006).
27. Watanabe, H. et al. Activation of the IL-1 β-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 127, 1956-1963 (2007). (Pubitemid 47075373)
28. Antonopoulos, C. et al. Functional caspase-1 is requi red for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 166, 3672-3677 (2001). (Pubitemid 32224888)
29. Weber, F. C. et al. Lack of the purinergic receptor P2X7 results in resistance to conta ct hypersensitivity. J. Exp. Med. 207, 2609- 2619 (2010).
30. Watanabe, H. et al. Danger signaling through the inflammasome acts as a master switch between tolerance and sensitization. J. Immunol. 180 , 5826-5832 (2008).
31. Steinbrink, K., Sorg, C. & Macher, E. Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells. J. Exp. Med. 183, 759-768 (1996). (Pubitemid 26113948)
32. Schmidt, M. et al. Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nature Immunol. 11, 814- 819 (2010).
33. Beltrani V. S. The role of house dust mites and other aeroallergens in atopic dermatitis Clin. Dermatol. 21 177-182 2003). (Pubitemid 36629329)
34. Trompette, A. et al. Allergenicity resulting from funct ional mimicry of a Toll-like receptor complex protein. Nature 457, 585-588 (2009).
35. Palmer, C. N. et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genet. 38, 441-446 (2006).
36. Novak, N. et al. Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J. Invest. Dermatol. 128 , 1430-1435 (2008). (Pubitemid 351693185)
37. Fallon, P. G. et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nature Genet. 41, 602-608 (2009).
38. Oyoshi, M. K., Murphy, G. F. & Geha, R. S. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. J. Allergy Clin. Immunol. 124, 485-493 (2009).
39. Scharschmidt, T. C. et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J. Allergy Clin. Immunol. 124, 496-506 (2009).
40. Lebre, M. C. et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127, 331-341 (2007). (Pubitemid 46106911)
41. Uchi, H., Terao, H., Koga, T. & Furue, M. Cytokines and chemokines in the epidermis. J. Dermatol. Sci. 24, S29-S38 (2000).
42. Corsini, E. & Galli, C. L. Epidermal cytokines in experimental contact dermatitis. Toxicology 142, 203-211 (2000). (Pubitemid 30009871)
43. Nishibu, A., Ward, B. R., Boes, M. & Takashima, A. Roles for IL-1 and TNFα in dynamic be havioral responses of Langerhans cells to topical hapten application. J. Dermatol. Sci. 45, 23-30 (2007). (Pubitemid 44969511)
44. Cumberbatch, M., Griffiths, C. E., Tucker, S. C., Dearman, R. J. & Kimber, I. Tumour necrosis factor-α induces Langerhans cell migration in humans. Br. J. Dermatol. 141 , 192-200 (1999). (Pubitemid 29397983)
45. Cumberbatch, M., Dearman, R. J. & Kimber, I. Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1 β for migration. Immunology 92, 388-395 (1997). (Pubitemid 27488152)
46. Pasparakis, M., Alexopoulou, L., Episkopou, V. & Kollias, G. Immune and inflam matory responses in TNFα-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184, 1397-1411 (1996). (Pubitemid 26354696)
47. Liu, Y. J. et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu. Rev. Immunol. 25 , 193-219 (2007).
48. Soumelis, V. et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunol. 3 , 673-680 (2002). (Pubitemid 34752477)
49. Ebner, S. et al. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J. Allergy Clin. Immunol. 119, 982-990 (2007). (Pubitemid 46527821)
50. Larson, R. P. et al. Dibutyl phthalate-induced thymic stromal lymphopoietin is required for Th2 contact hypersensitivity responses. J. Immunol. 184 , 2974-2984 (2010).
51. Loser, K. et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nature Med. 12 , 1372-1379 (2006). (Pubitemid 44924495)
52. Loser, K. & Beissert, S. Regulation of cutaneous immunity by the environment: an important role for UV irradiation and vitamin D. Int. Immunopharmacol. 9, 587-589 (2009).
53. Ghoreishi, M. et al. Expansion of antigen-specific regulatory T cells with the top ical vitamin D analog calcipotriol. J. Immunol. 182, 6071-6078 (2009).
54. Hanneman, K. K., Scull, H. M., Cooper, K. D. & Baron, E. D. Effect of topical vitamin D analogue on in vivo contact sensitization. Arch. Dermatol. 142 , 1332-1334 (2006). (Pubitemid 44583284)
55. Morioka, Y., Yamasaki, K., Leung, D. & Gallo, R. L. Cathelicidin antimicrobial peptides inhibit hyaluronan-induced cytokine release a nd modulate chronic allergic dermatitis. J. Immunol. 181, 3915-3922 (2008).
56. Nasir, A., Ferbel, B., Salminen, W., Barth, R. K. & Gaspari, A. A. Exaggerated and persistent cutaneous delaye d-type hypersensitivity in transgenic mice whose epidermal keratinocytes constitutively express B7-1 antigen. J. Clin. Invest. 94 , 892-898 (1994). (Pubitemid 24251025)
57. Williams, I. R., Ort, R. J. & Kupper, T. S. Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune response to cutaneous antigens. Proc. Natl Acad. Sci. USA 91 , 12780-12784 (1994).
58. Ferguson, T. A., Dube, P. & Griffith, T. S. Regulation of contact hypersensitivity by interleukin 10. J. Exp. Med. 179, 1597-1604 (1994). (Pubitemid 24129576)
59. Forster, R. et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99 , 23-33 (1999). (Pubitemid 29468627)
60. Itano, A. A. et al. Distinct dendritic cell populat ions sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19 , 47-57 (2003). (Pubitemid 36859900)
61. Allenspach, E. J., Lemos, M. P., Porrett, P. M., Turka, L. A. & Laufer, T. M. Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells. Immunity 29 , 795-806 (2008).
62. Ohl, L. et al. CCR7 governs skin dendritic cel l migration under inflammatory and steady-state conditions. Immunity 21, 279-288 (2004). (Pubitemid 39094056)
63. Chorro, L. et al. Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network. J. Exp. Med. 206, 3089-3100 (2009).
64. Merad, M. et al. Langerhans cells renew in the skin throughout life under steady-state conditions. Nature Immunol. 3, 1135-1141 (2002). (Pubitemid 35469697)
65. Romani, N., Clausen, B. E. & Stoitzner, P. Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol. Rev. 234, 120-141 (2010).
66. Henri, S. et al. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167, 741-748 (2001). (Pubitemid 32660827)
67. Bursch, L. S. et al. Identification of a novel population of langerin+ dendritic cells. J. Exp. Med. 204, 3147-3156 (2007).
68. Ginhoux, F. et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the st eady state. J. Exp. Med. 204, 3133-3146 (2007).
69. Poulin, L. F. et al. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204, 3119-3131 (2007).
70. Shklovskaya, E., Roediger, B. & Fazekas de St. Groth, B. Epidermal and dermal dendritic cells display differential activation and migratory behavior while sharing t he ability to stimulate CD4+ T cell proliferation in vivo. J. Immunol. 181, 418-430 (2008).
71. Ginhoux, F. et al. The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206, 3115-3130 (2009).
72. Henri, S. et al. CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207 , 189-206 (2010).
73. Edelson, B. T. et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells. J. Exp. Med. 207 , 823-836 (2010).
74. Merad, M., Ginhoux, F. & Collin, M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nature Rev. Immunol. 8, 935-947 (2008).
75. Le Borgne, M. et al. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo. Immunity 24, 191-201 (2006). (Pubitemid 43214588)
76. Ginhoux, F. et al. Langerhans cells arise from monocytes in vivo. Nature Immunol. 7 , 265-273 (2006).
77. Kaplan, D. H., Jenison, M. C., Saeland, S., Shlomchik, W. D. & Shlomchik, M. J. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23 , 611-620 (2005). (Pubitemid 41779483)
78. Bobr, A. et al. Acute ablation of Langerhans cells enhances skin immune responses. J. Immunol. 185, 4724-4728 (2010).
79. Igyarto, B. Z. et al. Langerhans cells suppress contact hypersensitivity responses vi a cognate CD4 interaction and Langerhans cell-derived IL-10. J. Immunol. 183 , 5085-5093 (2009).
80. Yoshiki, R. et al. IL-10-producing Langerhans cells and regulatory T cells are responsible for depresse d contact hypersensitivity in grafted skin. J. Invest. Dermatol. 129 , 705-713 (2009).
81. Obhrai, J. S. et al. Langerhans cells are not required for efficient skin graft rejection. J. Invest. Dermatol. 128, 1950-1955 (2008). (Pubitemid 352001229)
82. Kautz-Neu, K. et al. Langerhans cells are negative regulators of the anti-Leishmania response. J. Exp. Med. 208, 885-891 (2011).
83. Schwarz, A. et al. Langerhans cells are required for UVR-induced immunosuppression. J. Invest. Dermatol. 130, 1419-1427 (2010).
84. Fukunaga, A. et al. Langerhans cells serve as immunoregulatory cells by activating NKT cells. J. Immunol. 185, 4633- 4640 (2010).
85. Kissenpfennig, A. et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22, 643-654 (2005). (Pubitemid 40719199)
86. Bennett, C. L. et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J. Cell Biol. 169, 569-576 (2005). (Pubitemid 41002850)
87. Bennett, C. L., Noordegraaf, M., Martina, C. A. & Clausen, B. E. Langerhans cells are required for efficient present ation of topically applied hapten to T cells. J. Immunol. 179, 6830-6835 (2007).
88. Wang, L. et al. Langerin expressing cells promote skin immune responses under defined conditions. J. Immunol. 180, 4722-4727 (2008).
89. Kumamoto, Y., Denda-Nagai, K., Aida, S., Higashi, N. & Irimura, T. MGL2+ dermal dendritic cells are sufficient to initiate contact hypersensitivity in vivo. PLoS ONE 4 , e5619 (2009).
90. Honda, T. et al. Compensatory role of Langerhans cells and langerin-positive dermal dendritic cells in the sensitization phase of murine contact hypersensitivity. J. Allergy Clin. Immunol. 125, 1154-1156 (2010).
91. Noordegraaf, M., Flacher, V., Stoitzner, P. & Clausen, B. E. Functional redundancy of Langerhans cells and langerin+ dermal dendritic cells in con tact hypersensitivity. J. Invest. Dermatol. 130, 2752- 2759 (2010).
92. Bedoui, S. et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nature Immunol. 10, 488-495 (2009).
93. Igyarto, B. Z. et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35 , 260-272 (2011).
94. Marshall, J. S., King, C. A. & McCurdy, J. D. Mast cell cytokine and chemokine responses to bacterial and viral infection. Curr. Pharm. Des. 9, 11-24 (2003). (Pubitemid 36131702)
95. Abraham, S. N. & St. John, A. L. Mast cell-orchestrated immunity to pathogens. Nature Rev. Immunol. 10, 440-452 (2010).
96. Askenase, P. W. et al. Defective elicit ation of delayed-type hypersensitivity in W/Wv and SI/SId mast cell-deficient mice. J. Immunol. 131 , 2687-2694 (1983). (Pubitemid 14208815)
97. Galli, S. J. & Hammel, I. Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice. Science 226, 710-713 (1984). (Pubitemid 15202154)
98. Tsuji, R. F. et al. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J. Exp. Med. 196, 1277-1290 (2002). (Pubitemid 35375548)
99. Jawdat, D. M., Albert, E. J., Rowden, G., Haidl, I. D. & Marshall, J. S. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J. Immunol. 173, 5275-5282 (2004). (Pubitemid 39387811)
100. McLachlan, J. B., Catron, D. M., Moon, J. J. & Jenkins, M. K. Dendritic cell antigen presentation drives simultaneous cytokine production by effector and regulatory T cells in in flamed skin. Immunity 30, 277-288 (2009).
101. Kalesnikoff, J. & Galli, S. J. New developments in mast cell biology. Nature Immunol. 9 , 1215-1223 (2008).
102. Suto, H. et al. Mast cell-associated TNF promotes dendritic cell migration. J. Immunol. 176, 4102-4112 (2006). (Pubitemid 44264389)
103. Bryce, P. J. et al. Immune sensitization in the skin is enhanced by antige n-independent effects of IgE. Immunity 20, 381-392 (2004). (Pubitemid 38482117)
104. Grimbaldeston, M. A., Nakae, S., Kalesnikoff, J., Tsai, M. & Galli, S. J. Mast cell-derived interleukin 10 limits skin path ology in contact dermatitis and chronic irradiation with ultraviolet B. Nature Immunol. 8, 1095-1104 (2007). (Pubitemid 47423757)
105. Galli, S. J., Grimbaldeston, M. & Tsai, M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nature Rev. Immunol. 8, 478-486 (2008). (Pubitemid 351733419)
106. Scholten, J. et al. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res. 17 , 307-315 (2008).
107. Dudeck, A. et al. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34, 973- 984 (2011).
108. Strid, J. et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nature Immunol. 9 , 146-154 (2008).
109. Macleod, A. S. & Havran, W. L. Functions of skin-resident T cells. Cell. Mol. Life Sci. 68, 2399-2408 (2011).
110. Girardi, M. et al. Resident skin-specific T cells provide local, nonredundant regulation of cutaneous inflammation. J. Exp. Med. 195, 855-867 (2002). (Pubitemid 34286757)
111. Lewis, J. M. et al. Selection of the cutaneous intraepithelial T cell repertoire by a thymic stromal determinant. Nature Immunol. 7, 843-850 (2006). (Pubitemid 44084091)
112. Toulon, A. et al. A role for human skin-resident T cells in wound healing. J. Exp. Med. 206, 743-750 (2009).
113. DeGroot, A. Patch Testing: Test Concentrations and Vehicles for 2800 Allergens (Elsevier, New York, USA, 1986).
114. Vocanson, M., Hennino, A., Rozieres, A., Poyet, G. & Nicolas , J. F. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 64, 1699-1714 (2009).
115. Kupper, T. S. & Fuhlbrigge, R. C. Immune surveillance in the skin: mechanisms and clinical consequences. Nature Rev. Immunol. 4, 211-222 (2004). (Pubitemid 38339087)
116. Akiba, H. et al. Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J. Immunol. 168, 3079-3087 (2002). (Pubitemid 34211691)
117. Cavani, A. et al. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J. Immunol. 171 , 5760-5768 (2003). (Pubitemid 37467191)
118. Vocanson, M. et al. Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells. J. Allergy Clin. Immunol. 126, 280-289 (2010).
119. O' Leary, J. G., Goodarzi, M., Drayton, D. L. & von Andrian, U. H. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nature Immunol. 7, 507-516 (2006).
120. von Bubnoff, D. et al. Natural killer cells in atopic and autoimmune diseases of the skin. J. Allergy Clin. Immunol. 125, 60-68 (2010).
121. Carbone, T. et al. CD56highCD16-CD62L- NK cells accumulate in allergic contact dermatitis and contribute to the expression of allergic responses. J. Immunol. 184 , 1102-1110 (2010).
122. Balato, A., Unutmaz, D. & Gaspari, A. A. Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J. Invest. Dermatol. 129, 1628-1642 (2009).
123. Nieuwenhuis, E. E. et al. CD1d and CD1d-restricted iNKT-cells play a pivotal role in contact hypersensitivity. Exp. Dermatol. 14 , 250-258 (2005). (Pubitemid 40485452)
124. Campos, R. A. et al. Cutaneous immunization rapidly activates liver invariant Vα14 NKT cells stimulating B-1 B cells to initiate T cell recruitment for elicitation of contact sensitivity. J. Exp. Med. 198, 1785-1796 (2003). (Pubitemid 38032112)
125. Yusuf, N. et al. Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis. Cancer Res. 68 , 615-622 (2008). (Pubitemid 351380091)